Genome & Company (KONEX:GENOME)

1:30 PM - 1:45 PM, Thursday, June 6, 2019 ・ Theater 3
Genome & Company is a Korean biotech company applying high throughput screening, sophisticated analytics, and multi-omics to identify and develop naturally occurring microbiome to improve health. Currently, the company develops microbiome in oncology, metabolism, and skin area. The company is also developing monoclonal antibody therapeutics directed at the novel I/O targets. These programs are in the early preclinical stage of development.
Ticker:
GENOME
Exchange:
KONEX
Company Type:
Company Website:
Company HQ State:
Not Provided.
Company HQ Country:
Korea - South Korea
Year Founded:
2015
Main Therapeutic Focus:
Lead Product in Development:
GEN-001 (Microbiome)
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
5
Speaker
photo
CEO
www.genomecom.co.kr